Selected research
Market Analysis & Forecast
Global Armodafinil Tablets Market Analysis and Forecast 2026-2032
Market perspective
The global Armodafinil Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Armodafinil Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Armodafinil Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Armodafinil Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Armodafinil Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Armodafinil Tablets include Sandoz, Mylan, Aurobindo Pharma, Natco Pharma, Lupin, Cephalon, Apotex and Actavis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Armodafinil Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Armodafinil Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Armodafinil Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Armodafinil Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Armodafinil Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Armodafinil Tablets sales, projected growth trends, production technology, application and end-user industry.
Armodafinil Tablets Segment by Company
Sandoz
Mylan
Aurobindo Pharma
Natco Pharma
Lupin
Cephalon
Apotex
Actavis
Armodafinil Tablets Segment by Type
150mg per Tablet
200mg per Tablet
250mg per Tablet
50mg per Tablet
Armodafinil Tablets Segment by Application
Obstructive Sleep Apnea
Shift Work Sleep Disorder
Narcolepsy
Other
Armodafinil Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Armodafinil Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Armodafinil Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Armodafinil Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Armodafinil Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Armodafinil Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Armodafinil Tablets sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 150mg per Tablet
- 200mg per Tablet
- 250mg per Tablet
- 50mg per Tablet
Applications
- Obstructive Sleep Apnea
- Shift Work Sleep Disorder
- Narcolepsy
- Other
Companies covered
- Sandoz
- Mylan
- Aurobindo Pharma
- Natco Pharma
- Lupin
- Cephalon
- Apotex
- Actavis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Armodafinil Tablets Market by Type
- 1.2.1 Global Armodafinil Tablets Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 150mg per Tablet
- 1.2.3 200mg per Tablet
- 1.2.4 250mg per Tablet
- 1.2.5 50mg per Tablet
- 1.3 Armodafinil Tablets Market by Application
- 1.3.1 Global Armodafinil Tablets Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Obstructive Sleep Apnea
- 1.3.3 Shift Work Sleep Disorder
- 1.3.4 Narcolepsy
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Armodafinil Tablets Market Dynamics
- 2.1 Armodafinil Tablets Industry Trends
- 2.2 Armodafinil Tablets Industry Drivers
- 2.3 Armodafinil Tablets Industry Opportunities and Challenges
- 2.4 Armodafinil Tablets Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Armodafinil Tablets Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Armodafinil Tablets Revenue by Region
- 3.2.1 Global Armodafinil Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Armodafinil Tablets Revenue by Region (2021-2026)
- 3.2.3 Global Armodafinil Tablets Revenue by Region (2027-2032)
- 3.2.4 Global Armodafinil Tablets Revenue Market Share by Region (2021-2032)
- 3.3 Global Armodafinil Tablets Sales Estimates and Forecasts 2021-2032
- 3.4 Global Armodafinil Tablets Sales by Region
- 3.4.1 Global Armodafinil Tablets Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Armodafinil Tablets Sales by Region (2021-2026)
- 3.4.3 Global Armodafinil Tablets Sales by Region (2027-2032)
- 3.4.4 Global Armodafinil Tablets Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Armodafinil Tablets Revenue by Manufacturers
- 4.1.1 Global Armodafinil Tablets Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Armodafinil Tablets Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Armodafinil Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Armodafinil Tablets Sales by Manufacturers
- 4.2.1 Global Armodafinil Tablets Sales by Manufacturers (2021-2026)
- 4.2.2 Global Armodafinil Tablets Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Armodafinil Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Armodafinil Tablets Sales Price by Manufacturers (2021-2026)
- 4.4 Global Armodafinil Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Armodafinil Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Armodafinil Tablets Manufacturers, Product Type & Application
- 4.7 Global Armodafinil Tablets Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Armodafinil Tablets Market CR5 and HHI
- 4.8.2 2025 Armodafinil Tablets Tier 1, Tier 2, and Tier 3
5 Armodafinil Tablets Market by Type
- 5.1 Global Armodafinil Tablets Revenue by Type
- 5.1.1 Global Armodafinil Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Armodafinil Tablets Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Armodafinil Tablets Revenue Market Share by Type (2021-2032)
- 5.2 Global Armodafinil Tablets Sales by Type
- 5.2.1 Global Armodafinil Tablets Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Armodafinil Tablets Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Armodafinil Tablets Sales Market Share by Type (2021-2032)
- 5.3 Global Armodafinil Tablets Price by Type
6 Armodafinil Tablets Market by Application
- 6.1 Global Armodafinil Tablets Revenue by Application
- 6.1.1 Global Armodafinil Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Armodafinil Tablets Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Armodafinil Tablets Revenue Market Share by Application (2021-2032)
- 6.2 Global Armodafinil Tablets Sales by Application
- 6.2.1 Global Armodafinil Tablets Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Armodafinil Tablets Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Armodafinil Tablets Sales Market Share by Application (2021-2032)
- 6.3 Global Armodafinil Tablets Price by Application
7 Company Profiles
- 7.1 Sandoz
- 7.1.1 Sandoz Company Information
- 7.1.2 Sandoz Business Overview
- 7.1.3 Sandoz Armodafinil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Sandoz Armodafinil Tablets Product Portfolio
- 7.1.5 Sandoz Recent Developments
- 7.2 Mylan
- 7.2.1 Mylan Company Information
- 7.2.2 Mylan Business Overview
- 7.2.3 Mylan Armodafinil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Mylan Armodafinil Tablets Product Portfolio
- 7.2.5 Mylan Recent Developments
- 7.3 Aurobindo Pharma
- 7.3.1 Aurobindo Pharma Company Information
- 7.3.2 Aurobindo Pharma Business Overview
- 7.3.3 Aurobindo Pharma Armodafinil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Aurobindo Pharma Armodafinil Tablets Product Portfolio
- 7.3.5 Aurobindo Pharma Recent Developments
- 7.4 Natco Pharma
- 7.4.1 Natco Pharma Company Information
- 7.4.2 Natco Pharma Business Overview
- 7.4.3 Natco Pharma Armodafinil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Natco Pharma Armodafinil Tablets Product Portfolio
- 7.4.5 Natco Pharma Recent Developments
- 7.5 Lupin
- 7.5.1 Lupin Company Information
- 7.5.2 Lupin Business Overview
- 7.5.3 Lupin Armodafinil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Lupin Armodafinil Tablets Product Portfolio
- 7.5.5 Lupin Recent Developments
- 7.6 Cephalon
- 7.6.1 Cephalon Company Information
- 7.6.2 Cephalon Business Overview
- 7.6.3 Cephalon Armodafinil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Cephalon Armodafinil Tablets Product Portfolio
- 7.6.5 Cephalon Recent Developments
- 7.7 Apotex
- 7.7.1 Apotex Company Information
- 7.7.2 Apotex Business Overview
- 7.7.3 Apotex Armodafinil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Apotex Armodafinil Tablets Product Portfolio
- 7.7.5 Apotex Recent Developments
- 7.8 Actavis
- 7.8.1 Actavis Company Information
- 7.8.2 Actavis Business Overview
- 7.8.3 Actavis Armodafinil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Actavis Armodafinil Tablets Product Portfolio
- 7.8.5 Actavis Recent Developments
8 North America
- 8.1 North America Armodafinil Tablets Market Size by Type
- 8.1.1 North America Armodafinil Tablets Revenue by Type (2021-2032)
- 8.1.2 North America Armodafinil Tablets Sales by Type (2021-2032)
- 8.1.3 North America Armodafinil Tablets Price by Type (2021-2032)
- 8.2 North America Armodafinil Tablets Market Size by Application
- 8.2.1 North America Armodafinil Tablets Revenue by Application (2021-2032)
- 8.2.2 North America Armodafinil Tablets Sales by Application (2021-2032)
- 8.2.3 North America Armodafinil Tablets Price by Application (2021-2032)
- 8.3 North America Armodafinil Tablets Market Size by Country
- 8.3.1 North America Armodafinil Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Armodafinil Tablets Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Armodafinil Tablets Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Armodafinil Tablets Market Size by Type
- 9.1.1 Europe Armodafinil Tablets Revenue by Type (2021-2032)
- 9.1.2 Europe Armodafinil Tablets Sales by Type (2021-2032)
- 9.1.3 Europe Armodafinil Tablets Price by Type (2021-2032)
- 9.2 Europe Armodafinil Tablets Market Size by Application
- 9.2.1 Europe Armodafinil Tablets Revenue by Application (2021-2032)
- 9.2.2 Europe Armodafinil Tablets Sales by Application (2021-2032)
- 9.2.3 Europe Armodafinil Tablets Price by Application (2021-2032)
- 9.3 Europe Armodafinil Tablets Market Size by Country
- 9.3.1 Europe Armodafinil Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Armodafinil Tablets Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Armodafinil Tablets Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Armodafinil Tablets Market Size by Type
- 10.1.1 China Armodafinil Tablets Revenue by Type (2021-2032)
- 10.1.2 China Armodafinil Tablets Sales by Type (2021-2032)
- 10.1.3 China Armodafinil Tablets Price by Type (2021-2032)
- 10.2 China Armodafinil Tablets Market Size by Application
- 10.2.1 China Armodafinil Tablets Revenue by Application (2021-2032)
- 10.2.2 China Armodafinil Tablets Sales by Application (2021-2032)
- 10.2.3 China Armodafinil Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Armodafinil Tablets Market Size by Type
- 11.1.1 Asia Armodafinil Tablets Revenue by Type (2021-2032)
- 11.1.2 Asia Armodafinil Tablets Sales by Type (2021-2032)
- 11.1.3 Asia Armodafinil Tablets Price by Type (2021-2032)
- 11.2 Asia Armodafinil Tablets Market Size by Application
- 11.2.1 Asia Armodafinil Tablets Revenue by Application (2021-2032)
- 11.2.2 Asia Armodafinil Tablets Sales by Application (2021-2032)
- 11.2.3 Asia Armodafinil Tablets Price by Application (2021-2032)
- 11.3 Asia Armodafinil Tablets Market Size by Country
- 11.3.1 Asia Armodafinil Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Armodafinil Tablets Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Armodafinil Tablets Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Armodafinil Tablets Market Size by Type
- 12.1.1 SAMEA Armodafinil Tablets Revenue by Type (2021-2032)
- 12.1.2 SAMEA Armodafinil Tablets Sales by Type (2021-2032)
- 12.1.3 SAMEA Armodafinil Tablets Price by Type (2021-2032)
- 12.2 SAMEA Armodafinil Tablets Market Size by Application
- 12.2.1 SAMEA Armodafinil Tablets Revenue by Application (2021-2032)
- 12.2.2 SAMEA Armodafinil Tablets Sales by Application (2021-2032)
- 12.2.3 SAMEA Armodafinil Tablets Price by Application (2021-2032)
- 12.3 SAMEA Armodafinil Tablets Market Size by Country
- 12.3.1 SAMEA Armodafinil Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Armodafinil Tablets Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Armodafinil Tablets Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Armodafinil Tablets Value Chain Analysis
- 13.1.1 Armodafinil Tablets Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Armodafinil Tablets Production Mode & Process
- 13.2 Armodafinil Tablets Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Armodafinil Tablets Distributors
- 13.2.3 Armodafinil Tablets Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst